Ark

Ushering in the era of Computational Bioprocess

Boston, United States · Founded 2021 · $10.7M raised

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$10.7M
Last Round
$8.2M Series AJan 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Ark Biotech is a Boston-based computational bioprocess software company that provides an AI-powered platform enabling biopharma companies and CDMOs to simulate, optimize, and scale bioprocesses dramatically faster than traditional methods. The platform allows scientists to run virtual bioreactor experiments in seconds, simulate thousands of process variations to find optimal parameters, and scale up manufacturing first time right — without requiring coding or special data formats. Top biopharma companies and CDMOs trust Ark to shorten development timelines, reduce bioreactor runs, improve titer and process robustness, and achieve SOC 2 Type II certified secure operations.

Summary

Ark is an Artificial Intelligence company based in Boston, United States, founded in 2021. It has raised $10.7M in total across 2 rounds, most recently a $8.2M Series A round in Jan 2023. Investors include The Engine, Lowercase Capital and Night Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJan 2023
$8.2M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ark on Indexed.vc
<a href="https://indexed.vc/companies/ark"><img src="https://indexed.vc/api/badge/company/ark" alt="Ark on Indexed.vc" width="260" height="76" /></a>